ViaDerma Engages Intent Sciences to Power Up Digital Marketing & Brand Development
January 12, 2023 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Jan. 12, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (OTC Pink: VDRM) is pleased to announce that they have engaged the growth marketing services of INTENT SCIENCES who will help grow the...
ViaDerma's 2021 Annual Report Shows Strong Revenue Growth Over the Previous Year
March 31, 2022 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, March 31, 2022 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) announces the release of its 2021 Annual Report on the OTC Markets. The Company ended the year with...
ViaDerma, Inc. Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem Ultra
October 04, 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Oct. 04, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) is pleased to announce they are launching two new and improved formulas for its top selling product,...
ViaDerma Inc., Provides Review of 2020 and Looks Forward to 2021
January 13, 2021 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Jan. 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), President and CEO, Dr. Christopher Otiko offers a review of 2020 and provides a summary of his...
ViaDerma, Inc. Provides a Corporate Update
June 23, 2020 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, June 23, 2020 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to provide this corporate update: ViaDerma has partnered with the Brewer Group, Inc., to...
ViaDerma, Inc. Provides a Corporate Update
January 16, 2020 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Jan. 16, 2020 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to provide this corporate update: A new 55 ml spray bottle for use in hospitals has been...
ViaDerma Provides an Update to Shareholders via a Letter from the CEO
July 12, 2018 05:00 ET
|
ViaDerma, Inc.
LOS ANGELES, July 12, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to announce it has posted a letter from President and CEO, Dr. Christopher Otiko on the...
ViaDerma, Inc. Provides an Update of Current and Future Product Sales
April 02, 2018 08:20 ET
|
ViaDerma, Inc.
LOS ANGELES, April 02, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink:VDRM), is pleased to provide a update on current sales of the Company’s flagship product, Vitastem. ViaDerma...
ViaDerma, Inc. Refutes the Recent Announcement by Kasten, Inc.
March 02, 2018 09:15 ET
|
ViaDerma, Inc.
LOS ANGELES, March 02, 2018 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink:VDRM), announced today that it is refuting the announcement by Kasten, Inc. claiming he US District Federal Court ruled...
ViaDerma, Inc., to Initiate Upcoming Field Trial of Comparison for Onychomycosis
March 02, 2015 09:17 ET
|
ViaDerma Licensing
LOS ANGELES, March 2, 2015 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTCQB:VDRM) (The Company), a specialty pharmaceutical company devoted to bringing new products to market, is excited to start...